| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/09/2003 | EP1325324A1 Improved anti-viral and anti-tumor chemotherapy by administration of erythropoeitin |
| 07/09/2003 | EP1325153A2 Genetic determinants for dermal inflammation and immunity |
| 07/09/2003 | EP1325152A2 Method for detecting pre-disposition to hepatotoxicity |
| 07/09/2003 | EP1325144A2 Chromosomal vectors and uses thereof |
| 07/09/2003 | EP1325134A2 Method to alter sugar moieties |
| 07/09/2003 | EP1325125A2 Chromosome 3p21.3 genes are tumor suppressors |
| 07/09/2003 | EP1325122A2 Modulation of the transcription of pro-inflammatory gene products |
| 07/09/2003 | EP1325044A1 Aqueous polymer dispersion |
| 07/09/2003 | EP1325025A1 Peptide-based gemini surfactant compounds facilitating the transfer into cells |
| 07/09/2003 | EP1325019A1 Antisense modulation of clusterin expression |
| 07/09/2003 | EP1325014A2 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 07/09/2003 | EP1325010A1 Substituted 3.4-dihydro-pyrimido 1,2-a]pyrimidines and 3.4-dihydropyrazino 1,2-a]pyrimidines |
| 07/09/2003 | EP1325009A2 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same |
| 07/09/2003 | EP1325008A1 Piperazine derivatives |
| 07/09/2003 | EP1325007A2 Hexahydropyrazino[1'2':1,6]-pyrido[3,4-b]indole-1,4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction |
| 07/09/2003 | EP1325006A2 Heterocyclic compounds as ligands of the gaba a? receptor |
| 07/09/2003 | EP1325005A1 1,2,5,10-tetrahydropyridazino 4,5-b]quinoline-1,10-diones and their use for the treatment of pain |
| 07/09/2003 | EP1325004A1 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones and their use for the treatment of pain |
| 07/09/2003 | EP1325003A1 7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-tetrahydropyridazino 4,5-b]quinoline-1,10-dione and the use thereof for the treatment of pain |
| 07/09/2003 | EP1325002A1 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones and their use for the treatment of pain |
| 07/09/2003 | EP1325001A1 Anticholinergic agents that can be used as medicaments and method for the production thereof |
| 07/09/2003 | EP1325000A1 A thiazolidinedione derivative and its use as antidiabetic |
| 07/09/2003 | EP1324999A1 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and methods for preparing same |
| 07/09/2003 | EP1324998A1 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same |
| 07/09/2003 | EP1324997A2 Dioxolane analogs for improved inter-cellular delivery |
| 07/09/2003 | EP1324995A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 07/09/2003 | EP1324994A2 Tricyclic compounds and uses thereof |
| 07/09/2003 | EP1324992A1 Cyclized benzamide neurokinin antagonists for use in therapy |
| 07/09/2003 | EP1324991A1 Compounds useful in the treatment of inflammatory diseases |
| 07/09/2003 | EP1324990A1 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 07/09/2003 | EP1324986A1 Nitrogen-containing compounds and their use as glycine transport inhibitors |
| 07/09/2003 | EP1324985A1 Inhibitors of prenyl-protein transferase |
| 07/09/2003 | EP1324981A2 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors |
| 07/09/2003 | EP1324980A1 Citrullimycines, a process for their production and their use as pharmaceuticals |
| 07/09/2003 | EP1324974A2 Drugs for diabetes |
| 07/09/2003 | EP1324972A1 Dihydroxy open-acid salt of simvastatin |
| 07/09/2003 | EP1324970A2 Retinoids for the treatment of emphysema |
| 07/09/2003 | EP1324782A2 Stabilized hydrogen peroxide solutions |
| 07/09/2003 | EP1324780A2 Cardiac arrhythmia treatment methods |
| 07/09/2003 | EP1324774A2 Use of a ppar delta activator for treating inflammatory conditions |
| 07/09/2003 | EP1324773A2 Use of a ppar delta activator in the treatment of diseases related to no inhibition or tnf inhibition |
| 07/09/2003 | EP1324772A2 Methods for treating disorders of the female reproductive system |
| 07/09/2003 | EP1324766A2 Methods and compositions for the treatment of peripheral artery disease |
| 07/09/2003 | EP1324763A1 Stat3 agonists and antagonists and therapeutic uses thereof |
| 07/09/2003 | EP1324761A2 Uridine therapy for patients with elevated purine levels |
| 07/09/2003 | EP1324760A1 Creatine ester pronutrient compounds and formulations |
| 07/09/2003 | EP1324759A2 Nf-g(k)b inhibitors |
| 07/09/2003 | EP1324758A1 Method for preparing microspheres containing a water-soluble substance |
| 07/09/2003 | EP1324757A1 Protein prenyl transferase inhibitors in the treatment of neuroinflammatory disease |
| 07/09/2003 | EP1324756A2 Fatty acid analogues for the treatment of proliferative skin disorders |
| 07/09/2003 | EP1324755A1 Pharmaceutical solutions of modafinil compounds |
| 07/09/2003 | EP1324754A1 Pharmaceutical combination of an anti-androgen and tamoxifen for providing an anti-androgenic effect and aromatase inhibition |
| 07/09/2003 | EP1324753A2 Compositions and methods for lowering plasma lipoprotein(a) and risk factors of cardiovascular diseases |
| 07/09/2003 | EP1324750A1 Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment |
| 07/09/2003 | EP1324749A2 Medicinal aerosol formulations |
| 07/09/2003 | EP1324748A1 Topical antibiotic composition for treatment of eye infection |
| 07/09/2003 | EP1324663A1 Probes for targeting of cell density-indicating compounds |
| 07/09/2003 | EP1235810B1 Process of making substituted pyrazoles |
| 07/09/2003 | EP1200041A4 Sunscreen for the scalp and hair |
| 07/09/2003 | EP1175210A4 Increasing cerebral bioavailability of drugs |
| 07/09/2003 | EP1156798B1 Felbamate derived compounds |
| 07/09/2003 | EP1098871B1 alpha-AMINO ACID PHENYL ESTER DERIVATIVES |
| 07/09/2003 | EP1071752B1 CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF |
| 07/09/2003 | EP1066277B1 Polyethoxylated ascorbic acid derivatives as a novel antioxidant and process for preparing thereof |
| 07/09/2003 | EP1040096B1 Neuroprotective agents |
| 07/09/2003 | EP1031345B1 Gel preparation containing polystyrene-sulfonates |
| 07/09/2003 | EP1009385B1 Cholesterol level lowering composition |
| 07/09/2003 | EP1001778B1 Use of a rifamycin derivative for treating mastitis in a domestic animal |
| 07/09/2003 | EP0994703B1 Composition comprising ketanserin and l-carnitine for the treatment of crps |
| 07/09/2003 | EP0988306B1 3-substituted 3,4 dihydro-thieno 2, 3-d]pyrimidine derivatives and production and use of the same |
| 07/09/2003 | EP0983262B1 Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists |
| 07/09/2003 | EP0973768B1 Azole compounds, their production and their use |
| 07/09/2003 | EP0966465B1 Inhibitors of impdh enzyme |
| 07/09/2003 | EP0948500B1 Cyclic organoselenium compounds, their preparation and their uses |
| 07/09/2003 | EP0937067B1 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as hiv protease inhibitors |
| 07/09/2003 | EP0912558B1 Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors |
| 07/09/2003 | EP0912557B1 Oxindole derivatives |
| 07/09/2003 | EP0901483B1 Benzofurans and benzopyrans as chronobiological agents |
| 07/09/2003 | EP0894004B1 Method for enhancing functional recovery of motor coordination, speech or sensory perception after central nervous system ischemia or trauma |
| 07/09/2003 | EP0888353B1 N-7-HETEROCYCLYL PYRROLO [2,3-d]PYRIMIDINES AND THEIR USE |
| 07/09/2003 | EP0868188B1 Kit for female mammals, comprising a combination of gestagen and oestrogen |
| 07/09/2003 | EP0823906B1 Piperazino derivatives as neurokinin antagonists |
| 07/09/2003 | EP0788307B1 Oligonucleotide modulation of the expression of multidrug resistance-associated protein |
| 07/09/2003 | EP0752885B1 Therapeutic inhibitor of vascular smooth muscle cells |
| 07/09/2003 | EP0717631B1 Immunomodulating compositions from bile |
| 07/09/2003 | EP0612242B1 Use of the pure s(+) isomer of fluoxetine for the preparation of a medicament against migraine headache |
| 07/09/2003 | EP0573576B2 Compositions for topical administration of pharmaceutically active agents |
| 07/09/2003 | EP0190315B2 Dehydrated liposomes |
| 07/09/2003 | CN1429273A Protection against environmental toxicity through manipulation of processing of messenger RNA precursors |
| 07/09/2003 | CN1429233A Method of preparing clarithromycin of form II crystals |
| 07/09/2003 | CN1429232A Use of azalide antibiotic compositions for treating or preventing bacterial or protozoal infection in mammals |
| 07/09/2003 | CN1429226A Piperazine and piperidine compounds |
| 07/09/2003 | CN1429225A C10 carbonate substituted taxanes as antitumor agents |
| 07/09/2003 | CN1429222A 激酶抑制剂 Kinase inhibitors |
| 07/09/2003 | CN1429221A 2-phenylpyran-4-one derivatives |
| 07/09/2003 | CN1429220A Crystalline base of citalopram |
| 07/09/2003 | CN1429219A Method for preparation of citalopram |
| 07/09/2003 | CN1429215A 三唑衍生物 Triazole derivatives |
| 07/09/2003 | CN1429213A Substituted caprolactam carbonates and ethers and their use as anti-tumor agents |
| 07/09/2003 | CN1429212A Uses of thaliporphine or its derivatives in treatment of cardiac diseases and preparation of same |